Natural Killer Cell Stocks List

Related ETFs - A few ETFs which own one or more of the above listed Natural Killer Cell stocks.

Natural Killer Cell Stocks Recent News

Date Stock Title
Apr 23 IBRX ImmunityBio: Anktiva Approval Opens Up A World Of Possibilities, Risks And Potential Gains
Apr 23 IBRX ImmunityBio's bladder cancer therapy wins FDA approval
Apr 23 IBRX ImmunityBio: FDA Approval Gets Ball Rolling Towards Next Set Of Indications
Apr 23 IBRX ImmunityBio Lights Up: Anktiva's FDA Nod Shakes Up Bladder Cancer Battle
Apr 23 IBRX Biggest stock movers today: GM, DHR, IBRX, NVS, and more
Apr 23 IBRX ImmunityBio stock jumps as FDA clears bladder cancer therapy
Apr 23 IBRX ImmunityBio Announces FDA Approval of ANKTIVA®, First-in-Class IL-15 Receptor Agonist for BCG-Unresponsive Non-Muscle Invasive Bladder Cancer
Apr 22 CARM Carisma Therapeutics to Present New Data at the American Society of Gene and Cell Therapy (ASGCT) Annual Meeting
Apr 22 CELU Celularity Inc. to Host Investor and Analyst Research & Development Day
Apr 19 CELU Celularity receives Nasdaq notice regarding late Form 10-K filing
Apr 19 CELU Celularity Inc. Announces Receipt of Nasdaq Notice Regarding Late Form 10-K Filing
Apr 18 CELU Celularity Abstract “Emerging Technologies for the Management and Protection of Tendon Injuries: Decellularized Placental Biomaterials” Accepted at ORS Tendon Conference 2024
Apr 18 NKGN NKGen Biotech Announces Upcoming Presentation on SNK01 NK Cell Therapy in Neurodegenerative Disease at the 12th Annual Alzheimer’s & Parkinson’s Drug Development Summit
Apr 17 IBRX ImmunityBio files automatic mixed shelf
Apr 17 AFMD Affimed N.V. (AFMD) Forms 'Hammer Chart Pattern': Time for Bottom Fishing?
Natural Killer Cell

Natural killer cells, also known as NK cells or large granular lymphocytes (LGL), are a type of cytotoxic lymphocyte critical to the innate immune system. The role of NK cells is analogous to that of cytotoxic T cells in the vertebrate adaptive immune response. NK cells provide rapid responses to virus-infected cells, acting at around 3 days after infection, and respond to tumor formation. Typically, immune cells detect the major histocompatibility complex (MHC) presented on infected cell surfaces, triggering cytokine release, causing the death of the infected cell by lysis or apoptosis. NK cells are unique, however, as they have the ability to recognize and kill stressed cells in the absence of antibodies and MHC, allowing for a much faster immune reaction. They were named "natural killers" because of the notion that they do not require activation to kill cells that are missing "self" markers of MHC class 1. This role is especially important because harmful cells that are missing MHC I markers cannot be detected and destroyed by other immune cells, such as T lymphocyte cells.
NK cells can be identified by the presence of CD56 and the absence of CD3 (CD56+,CD3−). NK cells (belonging to the group of innate lymphoid cells) are one of the three kinds of cells differentiated from the common lymphoid progenitor, the other two being B and T lymphocytes. NK cells are known to differentiate and mature in the bone marrow, lymph nodes, spleen, tonsils, and thymus, where they then enter into the circulation. NK cells differ from natural killer T cells (NKTs) phenotypically, by origin and by respective effector functions; often, NKT cell activity promotes NK cell activity by secreting interferon gamma. In contrast to NKT cells, NK cells do not express T-cell antigen receptors (TCR) or pan T marker CD3 or surface immunoglobulins (Ig) B cell receptors, but they usually express the surface markers CD16 (FcγRIII) and CD57 in humans, NK1.1 or NK1.2 in C57BL/6 mice. The NKp46 cell surface marker constitutes, at the moment, another NK cell marker of preference being expressed in both humans, several strains of mice (including BALB/c mice) and in three common monkey species.In addition to natural killer cells being effectors of innate immunity, both activating and inhibitory NK cell receptors play important functional roles, including self tolerance and the sustaining of NK cell activity. NK cells also play a role in the adaptive immune response: numerous experiments have demonstrated their ability to readily adjust to the immediate environment and formulate antigen-specific immunological memory, fundamental for responding to secondary infections with the same antigen. The role of NK cells in both the innate and adaptive immune responses is becoming increasingly important in research using NK cell activity as a potential cancer therapy.

Browse All Tags